Investigating Probiotics to Support Maternal Gut Health
Discover how recent research is exploring the role of probiotics in improving gut health for pregnant women, aiming to address nutrient absorption issues and enhance maternal outcomes, especially in low-resource settings.
A recent study conducted by the Burnet Institute highlights the potential role of probiotics in improving gut health among pregnant women. The research aims to fill the current gap in clinical guidance for probiotic use during pregnancy, especially concerning environmental enteric dysfunction (EED). EED is a condition that predominantly affects children in low-resource settings, but it also impacts pregnant women by impairing nutrient absorption. This can lead to complications like anemia and hinder fetal growth, despite supplementation efforts.
Currently, there are no globally accepted treatments specifically targeting EED, and definitions for effective probiotic interventions in pregnant women are lacking. To address this, the study developed a comprehensive target product profile (TPP) for probiotics that could enhance maternal health outcomes. Published in PLOS One, this profile outlines necessary clinical and implementation standards for probiotic products, as well as analyzing potential candidates for future research.
Burnet research officer Kate Mills emphasized the importance of this work in accelerating research efforts. While many women already use probiotics during pregnancy, there is no structured framework guiding optimal candidate selection. The study recommends that probiotic interventions should ideally target populations broadly, especially in settings where EED prevalence is highest, and should prioritize affordability and stability without refrigerant requirements.
The research identified one high-potential and two medium-potential probiotic candidates currently in development. Though promising, further evidence is necessary to establish robust guidelines. The goal is to develop safe, effective, and accessible probiotic treatments that improve nutritional absorption and overall maternal health—especially in resource-limited areas.
This initiative aims to guide future clinical trials and product development, ultimately enhancing maternal and perinatal health worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Social, Cultural, and Economic Factors Influence Risk of Receiving Unsafe Medication
A national study reveals that social, cultural, and economic disparities significantly increase the risk of receiving unsafe or inappropriate medication, highlighting the need for targeted healthcare interventions.
Efficacy of Red Foxglove-derived Digitalis in Managing Heart Failure Confirmed by Clinical Research
A large clinical trial confirms that digitoxin from red foxglove significantly reduces mortality and hospitalizations in patients with heart failure with reduced ejection fraction, offering a safe, cost-effective treatment option.
Breakthrough in Understanding Tick-Borne Bacteria Opens Path for New Treatments
Researchers from the University of Missouri have identified new protein targets in the deadly bacterium Ehrlichia chaffeensis, opening promising avenues for future treatments of tick-borne diseases like ehrlichiosis.
Novel Target Identified for NRAS-Driven Melanoma via Genome-Wide CRISPR Screen
A groundbreaking genome-wide CRISPR study has identified SHOC2 as a key vulnerability in NRAS-driven melanoma, opening new avenues for targeted therapy in this challenging cancer subtype.